Agios Pharmaceuticals’ Post

The Ministry of Health Saudi Arabia and the Ministry of Health in Iraq are strengthening ties and collaborating in the establishment of medical centers and pharmaceutical factories in Iraq. In this collaborative effort, Saudi Arabia will provide grants to Iraq’s Ministry of Health to build multiple health centers across various provinces in Iraq. This collaboration will also foster cooperation between the private sectors of both nations to establish pharmaceutical facilities. #SaudiArabia #Iraq #Healthcare #Advancements #Collaboration #Partnerships

BREAKING NEWS! Vertex Pharmaceuticals Casgevy becomes the first therapy to secure approval from the SFDA - هيئة الغذاء والدواء under the breakthrough medicine program, marking a significant milestone in addressing #SickleCellDisease and #TransfusionDependentBetaThalassemia in the country. The Breakthrough Medicines Program, which was launched in October 2023, is dedicated to granting patients facing life-threatening or severely debilitating conditions access to promising new medicines in as quickly as 60 working days, marking a turning point in the #SpeedToAccess in Saudi Arabia. #MedicalInnovation #CasgevyApproval #sicklecelldisease #sicklecellwarriors #Vertex #HealthcareAdvancements #SaudiArabia

Saudi Arabia's pharmaceutical industry is on the brink of a major transformation, with a projected growth rate of 4.62% annually, leading to a market volume of $6.93 billion by 2029. (Source: Arab News) Follow WAM Saudi to witness this industry's remarkable shift firsthand. As a key sector driving economic diversification and healthcare advancement, Saudi Arabia's pharmaceutical industry offers unparalleled opportunities for growth and innovation. Discover the latest trends, insights, and breakthroughs from industry leaders who will be sharing their expertise at the World Advanced Manufacturing & Logistics Summit & Expo. Register your interest now at https://rb.gy/6vu126 and don't miss out on this exclusive opportunity to network with industry leaders, learn about cutting-edge technologies, and gain valuable insights into the future of pharmaceuticals, in the Kingdom and beyond. #PharmaceuticalRevolution #SaudiArabia #Healthcare #Innovation #Vision2030 #WAMSaudi #Summit #Expo #IndustryLeaders #Networking #Opportunities #FutureOfPharmaceuticals

On May 9, FrontierView gathered senior executives from pharmaceutical, medical device, and diagnostics companies for a moderated discussion on key market access and reimbursement challenges in the MENA region. Among the topics discussed were the creation of the Emirates Drug Establishment and implementation of unified procurement in the UAE, NUPCO’s evolving role and localization pressures in Saudi Arabia, as well as emerging opportunities in Algeria, Morocco, and Egypt. Some key takeaways from the discussion include: ➡ Executives expect unified procurement in the UAE to have an immediate impact on the Northern Emirates, with Dubai retaining autonomy in the medium-term.  ➡ Executives have seen the creation of the Emirates Drug Establishment as a positive step towards a more streamlined market access environment.  ➡ An increasing number of companies are being asked to show their RHQ application number when bidding on NUPCO tenders in Saudi Arabia, as well as commit to the Economic Participation Policy.  ➡ Executives are beginning to prepare for HTA implementation in Saudi Arabia by upskilling their existing teams and analyzing their product portfolios.  ➡ Executives see Algeria and Morocco as the biggest opportunities for growth outside of Saudi Arabia and the UAE in 2024, while retaining a cautiously optimistic approach to Egypt.  #healthcare #MENA

Discover the Africa Medicines Agency on CTC.AFRICA! Learn more about this crucial regulatory body and its role in advancing healthcare across the continent. Key points you'll find on the showcasing page: AMA's mission and vision: Understand their goals for regulating medicines in Africa. Regulatory framework: Explore the rules and guidelines governing the pharmaceutical industry. Key initiatives: Discover the AMA's ongoing projects and achievements. Visit CTC.AFRICA to explore the Africa Medicines Agency page and stay informed about the latest developments in African healthcare regulation. https://www.ctc.africa/ #CTCAfrica #AfricaMedicinesAgency #Healthcare #Regulation #Africa

I had the pleasure to speak today at the 1st Arab-Hellenic Health Conference in Athens, highlighting the achievements of the Jordanian pharmaceutical industry as a leading exporter in MENA through 27 local manufacturers and 20 Jordanian-owned pharmaceutical companies operating in 11 countries across Europe, US and MENA. This has resulted in creating thousands of jobs, positively influencing the trade balance, and improving access to medicines, therefore identified as a high value industry in Jordan Economic Medernisation Vision. The session also addressed the enablers to boost Arab-Arab & Arab-Greek collaboration in pharmaceutical field, to increase investments & improve access to generics and Biosimilars worldwide, these include regulatory convergence, strengthening regulatory systems & balanced IP rights. #Jordanian pharmaceutical industry #jordan Economic Modernisation Vision #access #biosimilars #balanced IP rights #regulatory convergence

Are you looking for the next big opportunity in the Pharmaceutical Industry? Mauritius is the smart choice for savvy investors seeking high-growth potential in the healthcare and biotech sectors. The Economic Development Board (EDB) of Mauritius provides support and guidance to investors, including facilitating permits, licenses, and approvals necessary for establishing and operating pharmaceutical businesses. With numerous nations and regional groups, including the African Continental Free Trade Area (AfCFTA) and COMESA (Common Market for Eastern and Southern Africa), Mauritius enjoys favorable trade accords. Reduced tariffs on pharmaceutical products and improved market access are two possible outcomes of these accords. Contact us now to learn more about the investment opportunities awaiting you in Mauritius. 📞+230 2033800 📨 bioindustry@edbmauritius.org 🌐 https://lnkd.in/gtcN3VYr #edbmauritius #pharma #investmentopportunities #businessdevelopment

New guideline alert! Last week, the SFDA - هيئة الغذاء والدواء released an updated version of their long-awaited Economic Evaluation Studies (EES) Guidelines. This updated guideline is expected to play a pivotal role in guiding economic data submissions for new therapies in Saudi Arabia, offering essential direction for pharmaceutical companies and healthcare manufacturers. Let’s explore the scope and objectives of this guideline and when it will come into effect! #SaudiArabia #SFDA #EES #EconomicEvaluation #Guideline #HTA

Our YallaRx team has recently concluded an exhaustive analysis of pharmaceutical registration trends within the KSA and UAE, and I am eager to share some pivotal insights derived from this study. In the UAE nonsteroidal anti-inflammatory and anti-rheumatic medications have seen a significant uptick, with an addition of 45 entries over the past two years, culminating in 417 registrations by 2023. Comparatively, the KSA has registered 255 of these medications. Notably, these are not novel compounds but primarily familiar substances such as paracetamol and its derivatives. For context, Belgium, with a larger population than the UAE, has only 151 such medications registered. This may be a signal that the local market is currently over heated with these molecules and within a short timeframe we will see the changes in the structure of portfolios of some distribution companies. This situation raises a critical inquiry: to what extent can this already saturated market continue to grow? Our data indicates a potential for over-saturation and underscores the necessity for strategic diversification in the sector. I urge manufacturers to explore other less saturated segments that hold growth potential. For example, a group of insulins and their analogs. There are 34 registrations in KSA for 2023 and 65 in UAE. In comparison, the Netherlands has 136 types of such medicines and Austria has 160. This comparison shows the prospects for this segment.  I am keen to hear your perspectives on these market dynamics. Are there other pharmaceutical niches that capture your interest? #PharmaTrends #GCCPharma #MarketInsights #UAEHealthCare #KSAHealthCare

The SFDA - هيئة الغذاء والدواء EES guidelines are a defining moment in pharma. We've developed a snapshot of the key objectives and timelines to watch out for. #MarketAccess #EconomicEvaluations #SFDA #Review #Submission